Man-in-the-plant: FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
U.S. Govt. Print. Off., 1978 - Drugs - 144 pages
11 pages matching priority in this book
Results 1-3 of 11
What people are saying - Write a review
We haven't found any reviews in the usual places.
6110 Robinwood Road advertising Alex Jones amoxicillin trihydrate ANDA antibiotic approved April April 17 Baltimore Barr Laboratories believe brand name brand-name drug Bureau of Drugs capsule Capsules 250 CARTWRIGHT certification Chairman changed Checks and signs Chlordiazepoxide chlorpromazine COHEN committee comprehensive inspection Consumer Safety Officer Cooper correct counsel Davis deceptive distributor document Drug Administration drug applications drug manufacturing facility facturer fiction firm Food and Drug Form 6 application Gore HADDAD Harrison HEALTH IIADDAD KARPERS label Leal lease Lederle Laboratories Lederle's legislation look manufacturing practices McEniry memo methods and processes MOFFETT Moss Mylan Pharmaceuticals operation package Parke Parke-Davis penicillin Peter Barton plant priority problem procedure proposed question referred to follows regulation require response SEIFE specifications staff subcommittee submitted Susan Leal tablets testimony testing Thank tion Tutag Walgren WUNDER Wyeth yield York State Assembly